This book analyses the effect of biological risk on business and management by considering case studies from Malaysia, Lebanon, and G20 countries during the COVID-19 pandemic. Covering a wide range of topics, such as effects of virus risk on corporate sustainability, COVID-19 and CSR activities, governance practices and regulations for derivative products in emerging markets, risk management during a pandemic, and AI applications in the health sector, this book assists top management in redesigning business models and organisational management in a post-pandemic world and in becoming better equipped to tackle future biological risks or pandemic events.